Form D · Venture Capital Fund
Qiming Biotech I, L.P.
Tortola, D8 · CIK 0002150194
Offering snapshot reported Aug 17, 2026 · SEC filing
- Reported sold
- $8M Offering amount: $8M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 11, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2026 | Initial | $8,000,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-594388
Source: Form D, filed Aug 17, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ho Man N/A Lam | Director |
| Grace Suk Han N/A Lee | Director |
| N/A N/A Qiming Biotech Gp, Ltd | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Gil (Bvi) Limited Craigmuir Chambers, Road Town
Tortola, D8, VG 1110
Tortola, D8, VG 1110